These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10623719)

  • 1. Premedication for irinotecan.
    Zampa G; Magnolfi E; Borgomastro A
    J Clin Oncol; 2000 Jan; 18(1):237. PubMed ID: 10623719
    [No Abstract]   [Full Text] [Related]  

  • 2. The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.
    Yumuk PF; Aydin SZ; Dane F; Gumus M; Ekenel M; Aliustaoglu M; Karamanoglu A; Sengoz M; Turhal SN
    Int J Colorectal Dis; 2004 Nov; 19(6):609-10. PubMed ID: 15293062
    [No Abstract]   [Full Text] [Related]  

  • 3. Irinotecan pharmacogenetics: is it time to intervene?
    McLeod HL; Watters JW
    J Clin Oncol; 2004 Apr; 22(8):1356-9. PubMed ID: 15007084
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan.
    Yau TC; Chu KW; Mok MY; Liang RH; Epstein RJ
    Acta Oncol; 2005; 44(7):771-2. PubMed ID: 16227172
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves irinotecan as first-line therapy for colorectal cancer.
    Oncology (Williston Park); 2000 May; 14(5):652, 654. PubMed ID: 10853457
    [No Abstract]   [Full Text] [Related]  

  • 6. [New drugs. Topoisomerase inhibitors].
    Gutzler F
    Zentralbl Gynakol; 1996; 118(10):579. PubMed ID: 8999716
    [No Abstract]   [Full Text] [Related]  

  • 7. Irinotecan-induced colitis.
    Sandmeier D; Chaubert P; Bouzourene H
    Int J Surg Pathol; 2005 Apr; 13(2):215-8. PubMed ID: 15864388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of acetylcholinesterase in patients receiving irinotecan (camptothecin-11).
    Tobin P; Rivory L; Clarke S
    Clin Pharmacol Ther; 2004 Nov; 76(5):505-6; author reply 507-8. PubMed ID: 15536465
    [No Abstract]   [Full Text] [Related]  

  • 9. Irinotecan in cervical cancer.
    Kavanagh JJ; Verschraegen CF; Kudelka AP
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):94-8. PubMed ID: 9726099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyoscine and glycopyrrolate for death rattle.
    Murtagh FE; Thorns A; Oliver DJ
    Palliat Med; 2002 Sep; 16(5):449-50; author reply 450. PubMed ID: 12380666
    [No Abstract]   [Full Text] [Related]  

  • 11. Scopolamine?
    Selman D
    J Am Coll Cardiol; 2002 Feb; 39(4):744-5. PubMed ID: 11849885
    [No Abstract]   [Full Text] [Related]  

  • 12. Audit of three antimuscarinic drugs for managing retained secretions.
    Hughes A; Wilcock A; Corcoran R; Lucas V; King A
    Palliat Med; 2000 May; 14(3):221-2. PubMed ID: 10858832
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology and pharmacodynamics of irinotecan. A review.
    Chabot GG
    Ann N Y Acad Sci; 1996 Dec; 803():164-72. PubMed ID: 8993509
    [No Abstract]   [Full Text] [Related]  

  • 14. Irinotecan for colorectal cancer: a small step forward.
    O'Connell MJ
    Lancet; 1998 Oct; 352(9138):1402. PubMed ID: 9807982
    [No Abstract]   [Full Text] [Related]  

  • 15. New potential uses for transdermal scopolamine (hyoscine).
    La Rovere MT; De Ferrari GM
    Drugs; 1995 Nov; 50(5):769-76. PubMed ID: 8586025
    [No Abstract]   [Full Text] [Related]  

  • 16. Irinotecan for metastatic colorectal cancer.
    Med Lett Drugs Ther; 1997 Jan; 39(992):8. PubMed ID: 9008684
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolving role of irinotecan: a broad-spectrum chemotherapeutic agent. Introduction.
    Ajani JA
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):17-8. PubMed ID: 11200142
    [No Abstract]   [Full Text] [Related]  

  • 18. [Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials].
    Mitry E; Ducreux M; Rougier P
    Bull Cancer; 1998 Dec; Spec No():38-42. PubMed ID: 9932083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irinotecan hydrochloride for treatment of advanced breast cancers].
    Morimoto K; Kou M; Kinoshita H
    Nihon Rinsho; 2000 Apr; 58 Suppl():265-70. PubMed ID: 11026005
    [No Abstract]   [Full Text] [Related]  

  • 20. Oesophageal spasm, vomiting and hyoscine hydrobromide patch.
    Murray-Brown F; Davies IL
    BMJ Support Palliat Care; 2016 Mar; 6(1):125-7. PubMed ID: 26667134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.